On the public citation graph
Safety and Efficacy of Preventative COVID Vaccines: The StopCoV Study
0 signed · 35 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2021.15072openalex-snapshot
Surveillance for Adverse Events After COVID-19 mRNA Vaccination
inferredcites →https://doi.org/10.1001/jama.2021.15125openalex-snapshot
Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273
inferredcites →https://doi.org/10.1001/jama.2021.21921openalex-snapshot
Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals
inferredcites →https://doi.org/10.1001/jama.2021.5374openalex-snapshot
Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines
inferredcites →https://doi.org/10.1002/cti2.1380openalex-snapshot
A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination
inferredcites →https://doi.org/10.1016/s0140-6736(21)00575-4openalex-snapshot
Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study
inferredcites →https://doi.org/10.1016/s2666-5247(21)00267-6openalex-snapshot
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
inferredcites →https://doi.org/10.1038/s41467-021-27410-5openalex-snapshot
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
inferredcites →https://doi.org/10.1038/s41541-022-00432-wopenalex-snapshot
Extended interval BNT162b2 vaccination enhances peak antibody generation
inferredcites →https://doi.org/10.1038/s41564-021-00947-3openalex-snapshot
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
inferredcites →https://doi.org/10.1038/s41586-021-03739-1openalex-snapshot
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
inferredcites →https://doi.org/10.1038/s41591-021-01377-8openalex-snapshot
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
inferredcites →https://doi.org/10.1056/nejmc2110716openalex-snapshot
Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination
inferredcites →https://doi.org/10.1056/nejmc2112981openalex-snapshot
Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce
inferredcites →https://doi.org/10.1056/nejmoa1315727openalex-snapshot
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
inferredcites →https://doi.org/10.1056/nejmoa2027906openalex-snapshot
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
inferredcites →https://doi.org/10.1056/nejmoa2034577openalex-snapshot
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
inferredcites →https://doi.org/10.1056/nejmoa2035389openalex-snapshot
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
inferredcites →https://doi.org/10.1056/nejmoa2110475openalex-snapshot
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
inferredcites →https://doi.org/10.1056/nejmoa2115463openalex-snapshot
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans
inferredcites →https://doi.org/10.1056/nejmoa2116063openalex-snapshot
Covid-19 Vaccine Effectiveness in New York State
inferredcites →https://doi.org/10.1093/cid/ciab381openalex-snapshot
Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination
inferredcites →https://doi.org/10.1093/infdis/jiab592openalex-snapshot
Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults
inferredcites →https://doi.org/10.1101/2021.08.06.21261721openalex-snapshot
Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers
inferredcites →https://doi.org/10.1126/science.abd7728openalex-snapshot
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
inferredcites →https://doi.org/10.1126/sciimmunol.abe5511openalex-snapshot
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
inferredcites →https://doi.org/10.1371/journal.pone.0237833openalex-snapshot
High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay
inferredcites →https://doi.org/10.1371/journal.pone.0258516openalex-snapshot
Development of at-home sample collection logistics for large-scale seroprevalence studies
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/cti2.1380openalex-snapshot
A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination
inferred← citeshttps://doi.org/10.1080/21645515.2023.2293550openalex-snapshot
A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study
inferred← citeshttps://doi.org/10.1093/ageing/afad229openalex-snapshot
The association between frailty, long-term care home characteristics and COVID-19 mortality before and after SARS-CoV-2 vaccination: a retrospective cohort study
inferred← citeshttps://doi.org/10.1128/spectrum.01134-22openalex-snapshot
A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021
inferred← citeshttps://doi.org/10.1136/bmj-2022-071502openalex-snapshot
Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study
inferred← citeshttps://doi.org/10.1177/10704965241311356openalex-snapshot
Multidimensional Stressors Among Historically Marginalized Indigenous People in Highland Communities: Empirical Insights From the Q’ero of Peru
inferred← citeshttps://doi.org/10.1371/journal.pdig.0000242openalex-snapshot
Decentralized study of COVID Vaccine Antibody Response (STOPCoV): Results of a participant satisfaction survey
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.